Which hedge funds own BSTC? BIOSPECIFICS TECHNOLOGIES CO, Q2 2026 13F holders

0 tracked hedge funds disclosed a position in BSTC (BIOSPECIFICS TECHNOLOGIES CO) in their Q2 2026 13F filings, worth $0 in total.

0

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

0

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

0

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$0

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$0

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$0

Combined value

Sum of the holders' reported positions in the security.

–

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.